Abstract 116: Proof Of Biological Activity And Exploration Of Early Signaling Events Of Angiotensin-(1-5)

Igor M. Silva Souza, Augusto Peluso, Arkadiusz Nawrocki, Lene Andrup Jakobsen, Pia Jensen, Lucas Rodrigues-Ribeiro, Christina Mortensen, Colin Sumners, Thiago Verano-Braga, Martin Røssel Larsen, Ulrike Muscha Steckelings

Research output: Contribution to journalConference abstract in journalResearch


Recombinant human ACE2 increases the circulating levels of angiotensin-(1-5) [Ang-(1-5)], a peptide thus far regarded as biologically inactive. Since ACE2 is a central component of the protective RAS, we hypothesized that Ang-(1-5) is a new biologically active peptide within this hormonal system.
Objective: To investigate biological activity and signaling mechanisms of Ang-(1-5). Methods In order to show a biological effect and to test whether Ang-(1-5) signals through the AT2-receptor (AT2R), nitric oxide (NO) release was measured by DAF-FM fluorescence in AT2R-transfected (AT2R-CHO) or non-transfected (NT-CHO) CHO cells, treated with Ang-(1-5) or C21 (AT2R agonist, positive control) (0.1nM to 10μM) for 15 minutes. Vehicle (cell media) treated cells served as negative control. To investigate Ang-(1-5) signaling patterns, human aortic endothelial cells (HAEC) were treated with vehicle or Ang-(1-5) (1μM) for 1, 3, 5 or 20 minutes. Proteins were harvested, digested and labeled with TMTpro-16plex. Phosphopeptide enrichment was carried out by TiO2. Samples were subjected to LC-MS/MS analysis and the resulting mass spectra were searched against the human SwissProt database. Results: Ang-(1-5) induced a concentration-dependent increase in NO production in AT2-CHO cells (Emax 65.60 ± 14.02%), thus proving its biological activity. Ang-(1-5) had 69% higher efficacy than the established AT2R agonist C21 (Emax 38.76 ± 10.24%). Ang-(1-5) seems to signal through the AT2R, because effects on NO release were absent in NT-CHO cells. Treatment of HAEC with Ang-(1-5) significantly modified the phosphorylation status of 831 proteins at 1799 residues. The majority of residues (1079) were dephosphorylated while 729 residues were phosphorylated. Changes in protein phosphorylation in response to Ang-(1-5) occurred at all investigated time points, most of them after 20 minutes. Functional bioinformatic analysis revealed a cluster of proteins involved in cell cycle and cell division regulation. Conclusion: This study provides evidence that Ang-(1-5) is an endogenous AT2R agonist with high efficacy towards the AT2R. The early signaling phosphorylation pattern resembles those of other protective RAS agonists, such as C21 and Ang-(1-7).
Original languageEnglish
Issue numberSuppl. 1
Pages (from-to)A116
Publication statusPublished - Sept 2022
EventHypertension Scientific Sessions 2022 - San Diego, United States
Duration: 7. Sept 202210. Sept 2022


ConferenceHypertension Scientific Sessions 2022
Country/TerritoryUnited States
CitySan Diego
Internet address


Dive into the research topics of 'Abstract 116: Proof Of Biological Activity And Exploration Of Early Signaling Events Of Angiotensin-(1-5)'. Together they form a unique fingerprint.

Cite this